Related Experiment Video
Updated: Jul 26, 2026

08:38
Quantification of the Immunosuppressant Tacrolimus on Dried Blood Spots Using LC-MS/MS
Published on: November 8, 2015
Dried-blood spot screening for cystic fibrosis in the newborn
Lancet (London, England)
|March 3, 1979
Insights
Serum-immunoreactive-trypsin (IRT) is elevated in infants with cystic fibrosis (CF). A new dried blood-spot assay for IRT shows promise as a newborn screening test for CF.
Area of Science:
- Biochemistry
- Pediatrics
- Genetics
Background:
- Cystic Fibrosis (CF) is a genetic disorder affecting multiple organs.
- Early diagnosis of CF is crucial for timely intervention and improved outcomes.
- Serum-immunoreactive-trypsin (IRT) is a biomarker associated with pancreatic dysfunction in CF.
Purpose of the Study:
- To measure serum-immunoreactive-trypsin (IRT) levels in children diagnosed with cystic fibrosis (CF).
- To evaluate the potential of a dried blood-spot assay for IRT as a newborn screening tool for CF.
Main Methods:
- Serum samples were collected from children with CF and control groups.
- Immunoreactive-trypsin (IRT) levels were quantified in serum.
- A novel assay using dried blood spots for IRT measurement was developed and validated.
Main Results:
- All infants diagnosed with CF exhibited elevated serum-IRT levels within the first few months of life.
- The established dried blood-spot assay demonstrated feasibility for IRT measurement.
- The assay showed potential for widespread application in newborn screening programs.
Conclusions:
- Elevated serum-IRT is a consistent finding in early infancy for children with CF.
- A dried blood-spot IRT assay is a viable method for newborn screening.
- This assay could facilitate early detection and management of cystic fibrosis.
Abstract:
Serum-immunoreactive-trypsin (I.R.T.) was measured in children with cystic fibrosis (C.F.) and a variety of controls. In the first few months of life all C.F. children had a raised serum-I.R.T. A dried blood-spot assay for I.R.T. was established and has potential as a screening test for C.F. in the newborn.

